this post was submitted on 16 Mar 2020
1 points (100.0% liked)

Science

13192 readers
17 users here now

Subscribe to see new publications and popular science coverage of current research on your homepage


founded 5 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 1 points 1 year ago* (last edited 1 year ago)

Researchers tested the drug, not yet on the market, in mouse models of Lyme disease at seven-day, 14-day, and 21-day intervals and found that it eliminated the infection. For the first time, azlocillin also proved effective in killing drug-tolerant forms of B. burgdorferi in lab dishes, indicating that it may work as a therapy for lingering symptoms of Lyme disease.

Researchers plan to conduct a clinical trial.

One day... Maybe.